1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, and CX3CR1
Details for Australian Patent Application No. 2009221063 (hide)
International Classifications
Event Publications
9 September 2010 PCT application entered the National Phase
PCT publication WO2009/109654 Priority application(s): WO2009/109654
1 March 2012 Amendment Made
The nature of the amendment is: Amend the invention title to read 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, and CX3CR1
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009221064-Pharmaceutical compositions for treatment of microRNA related diseases
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser